February 27, 2023 07:27 AM ESTUpdated 07:57 AM

Glenmark's biotech company Ichnos Sciences lays off 50

Kyle LaHucik

Senior Reporter

Ichnos Sciences, an innovation unit launched out of generics maker Glenmark in 2019, is laying off about 50 workers out of approximately 225 employees, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Glenmark's biotech company Ichnos Sciences lays off 50

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Bristol Myers CEO signals dealmaking will be a top priority in 2025

Drugmakers see a substantial, but manageable, hit to business from tariffs. But the worst may lie ahead

Roche CEO warns that tariffs could impact dealmaking

Merck is ‘well-positioned’ on Keytruda ahead of threatened pharma tariffs, CEO says

Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Glen­mark's biotech com­pa­ny Ich­nos Sci­ences lays off 50

Senior Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Glenmark's biotech company Ichnos Sciences lays off 50